MIM
ACLX

MetLife Investment Management’s Arcellx ACLX Stock Holding History

MetLife Investment Management’s Portfolio ACLX Stock Details ACLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.4M Buy
20,914
+1,570
+8% +$139K 0.01% 959
2025
Q4 		$1.26M Sell
19,344
-679
-3% -$54.2K 0.01% 1303
2025
Q3 		$1.64M Sell
20,023
-1,926
-9% -$139K 0.01% 1192
2025
Q2 		$1.45M Sell
21,949
-3,661
-14% -$228K 0.01% 1140
2025
Q1 		$1.68M Sell
25,610
-448
-2% -$30.3K 0.01% 1124
2024
Q4 		$2M Buy
26,058
+1,077
+4% +$93K 0.01% 1038
2024
Q3 		$2.09M Hold
24,981
– – 0.01% 996
2024
Q2 		$1.38M Buy
24,981
+5,387
+27% +$293K 0.01% 1171
2024
Q1 		$1.36M Sell
19,594
-590
-3% -$37.4K 0.01% 1129
2023
Q4 		$1.12M Hold
20,184
– – 0.01% 1232
2023
Q3 		$724K Hold
20,184
– – 0.01% 1409
2023
Q2 		$638K Buy
20,184
+3,338
+20% +$128K ﹤0.01% 1538
2023
Q1 		$519K Sell
16,846
-21,490
-56% -$652K ﹤0.01% 1613
2022
Q4 		$1.19M Buy
38,336
+21,490
+128% +$493K 0.01% 1132
2022
Q3 		$316K Buy
+16,846
New +$322K ﹤0.01% 1980

Other funds holding ACLX

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

MetLife Investment Management's ACLX Position: Q1 2026 in Review

MetLife Investment Management increased its Arcellx (ACLX) stake by 8.1% in Q1 2026, buying an estimated $139K and bringing the position to 20,914 shares worth $2.4M. The position accounts for 0.01% of the portfolio, ranked #959.

MetLife Investment Management first reported a position in ACLX in Q3 2022 and has held it in 15 quarters since. 239 funds tracked by Wall St. Rank hold ACLX as of Q1 2026.

  • MetLife Investment Management held 20,914 shares of Arcellx worth $2.4M as of Q1 2026.
  • MetLife Investment Management bought 1,570 Arcellx shares in Q1 2026, an estimated $139K.
  • Arcellx made up 0.01% of MetLife Investment Management's portfolio in Q1 2026, its #959 holding.
  • MetLife Investment Management first reported a position in Arcellx in Q3 2022 and has held it in 15 quarters since.
  • 239 funds tracked by Wall St. Rank held Arcellx as of Q1 2026.

Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.